Hookipa Biotech - Articles and news items

First-in-human study of CMV vaccine HB-101 starts

Industry news / 20 July 2016 / Victoria White, Digital Content Producer

Hookipa Biotech has announced the start of a first-in-human study to evaluate the safety and immunogenicity of HB-101 against human cytomegalovirus…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+